Journal of Hematology and Transfusion Medicine Vol. 36 No. 1 January-March 2026 | สมาคมโลหิตวิทยาแห่งประเทศไทย (The Thai Society of Hematology)

Journal of Hematology and Transfusion Medicine Vol. 36 No. 1 January-March 2026

ปีที่ 36 ฉบับที่ 1 · ม.ค. 2569

00 Editor & Content 36-1

01 Editor's note

02 Blood services in Thailand: 2025 perspectives [Editorial]

03 Direct oral anticoagulants (DOACs): benefits, limitations, and cost-effectiveness considerations in Thailand [Editorial]

04 Anti-H lectin Momordica charantia blood grouping reagents produced by the National Blood Centre, Thai Red Cross Society [Original article]

05 HLA class II allele and haplotype frequencies in deceased kidney donors and the significance of HLA-DQ matching on allograft survival: a retrospective study from January 2019 to December 2024 [Original article]

06 Cost-effectiveness analysis of warfarin and direct oral anticoagulants for the treatment of venous thromboembolism in Ramathibodi Hospital [Original article]

07 Appropriateness of self- and caregiver reports in measuring health utility in Thai pediatric cancer patients [Original article]

08 How to appropriately manage patients with paroxysmal nocturnal hemoglobinuria [Literature review]

09 Anti-I alloantibody in an adult patient with the rare i phenotype: a case report [Case report]

10 Phenytoin-induced pure red cell aplasia: a rare and challenging diagnosis [Case report]

11 Potential and limitations of blockchain technology in blood quality tracking and verification: approaches for blood bank systems [Special article]

12 ประกาศให้ทุน